Ami Organcis IPO to open on Sept 1 at a fixed price band of Rs603-610 per equity share
Ami Organcis IPO to open on Sept 1 at a fixed price band of Rs603-610 per equity share
The Minimum Bid Lot is 24 Equity Shares and in multiples of 24 Equity Shares thereafter.
Ami Organics Limited proposes to open its Initial Public Offering on Wednesday, September 01, 2021 and the offer will close on Friday, September 03, 2021.
The Price Band of the offer has been fixed at Rs 603 to Rs 610 per Equity Share.
Bids can be made for a minimum of 24 Equity Shares and in multiple of 24 Equity Shares thereafter.
The Initial Public Offering comprises of fresh issue of equity shares of face value Rs10 each (“Equity Shares”). The Offer comprises of fresh issue of such number of Equity Shares aggregating up to Rs. 200 crores (“Fresh Issue”) and an offer of sales of up to 6,059,600 Equity Shares, constituting up to 700,000 Equity Shares by Parul Chetankumar Vaghasia (“Promoter Selling Shareholder”), Up to 1,500,000 Equity Shares by Girishkumar Limbabhai Chovatia, Up to 3,050,000 equity shares by Kiranben Girishbhai Chovatia, Up to 174,600 Equity Shares by Aruna Jayantkumar Pandya (jointly held with Jayant Manubhai Pandya), Up to 87,300 Equity Shares by Hina Indreshbhai Shah, up to 87, 280 Equity Shares by Harshad Ramlal Sheth, up to 76,200 Equity Shares by Dhirajlal Amrutlal Amlani, up to 75,000 Equity Shares by Vrushti Atulkumar Shah, Up to 63,000 Equity Shares by Jolitbhai Jasvantlal Shah (jointly held with Amitaben Jolitbhai Shah), Up to 55,920 Equity Shares by Nishit Atulkumar shah, Up to 49,000 Equity Shares by Surabhi Yash Shah, Up to 32,000 Equity Shares by Narmada Amrutlal Amlani, Up to 26,500 Equity Shares by Shanti Devi Kankaria, Up to 19,000 Equity Shares by Divya Mahendrakumar Kankaria, Up to 15,000 Equity Shares by Chovatiya Haresh H, Up to 14,910 Equity Shares by Amitaben Jolitbhai Shah(jointly held with Jolitbhai Jasvantlal Shah), Up to 14,500 Equity Shares by Saryu Dhirajlal Amlani, Up to 10,000 Equity Shares by Koladia Mehul M, Up to 8700 Equity Shares by Jyotiben Rakeshbhai Lahoti (jointly held with Rakesh Baluram Lahoti) and Up to 690 Equity Shares by Shah Disha Jolit (jointly held with Jolitbhai Jasvantlal Shah) (“Collectively, ”Selling Shareholders” and such Equity Shares “Offered Shares”) (“Offer For Sale” and together with the Fresh Issue, the “Offer”).
Further, the Company in consultation with the BRLMs (defined below), has undertaken a Pre-IPO placement of Equity Shares aggregating to Rs100cr (The “Pre-IPO Placement”). The size of the Fresh Issue has been reduced by Rs100cr pursuant to the Pre-IPO placement. Accordingly, the Fresh Issue size is up to Rs200cr.
The Offer is being made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (“SCRR”) read with Regulation 31 of the SEBI ICDR Regulations and in compliance with Regulation 6(1) of the SEBI ICDR Regulations, wherein not more than 50% of the Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (“QIBs” and such allocation, the “QIB Portion”), provided that our Company and the Selling Shareholders may, in consultation with the BRLMs, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations (“Anchor Investor Portion”), of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price. In the event of under-subscription, or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the Net QIB Portion.
Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIBs, including Mutual Funds, subject to valid Bids being received at or above the Offer Price.
Further, not less than 15% of the Offer shall be available for allocation on a proportionate basis to Non-Institutional Bidders (“NIB”) and not less than 35% of the Offer shall be available for allocation to Retail Individual Bidders (“RIB”) in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price. All Bidders (except Anchor Investors) are required to mandatorily participate in the Offer only through the Application Supported by Blocked Amount (“ASBA”) process by providing details of their respective ASBA Accounts (including UPI ID in case of RIBs, if applicable) which will be blocked by the SCSBs, or the Sponsor Bank, as applicable, to participate in the Offer. Anchor Investors are not permitted to participate in the Anchor Investor Portion through the ASBA process.
The net proceeds of Fresh Issue i.e. Gross proceeds of the Fresh Issue less the Offer expenses apportioned to the company (“Net Proceeds”) and the proceeds from Pre-IPO placement are proposed to be utilised towards (i) Repayment / prepayment of certain financial facilities availed by the company amounting to Rs140cr; (ii) Funding working capital requirements of the company amounting to Rs90cr and (iii) General corporate purpose
In addition, the company expects to achieve the benefits of listing the Equity Shares on the Stock Exchanges, to enhance its visibility and brand image among existing and potential customers and creation of a public market for its Equity Shares in India.
The proceeds of the Offer for Sale shall be received by the Selling Shareholders. The Company will not receive any proceeds from the Offer for Sale. The Selling Shareholders will be entitled to the proceeds from the Offer for Sale, net of their respective portion of the Offer related expenses and relevant taxes thereon
Company will not receive any proceeds from the Offer for Sale and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.
Company expects that listing of the Equity Shares will enhance its visibility and brand image and provide liquidity to Shareholders and will also provide a public market for the Equity Shares in India.
Intensive Fiscal Services Private Limited, Ambit Private Limited and Axis Capital Limited are the Book Running Lead Managers (“BRLMs”) to the issue.
The Company derives 64.98% of total revenue from sale of products from India and 35.02% of total revenue from the sale of products from Europe, the USA and other foreign countries combined. Below are the 10 things to know about the Sansera Engineering
Bid can be made for a minimum of 24 Equity Shares and in multiples of 24 Equity Shares thereafter. Ami Organics Limited has allocated 28,01,485 equity shares to 20 anchor investors and raised Rs170.89cr ahead of the company’s proposed IPO at the upper
The price band for the public issue has been fixed at Rs522-531. Vijaya Diagnostic has finalized 29 anchor investors, allotting 10,661,418 shares at Rs531 per share aggregating Rs566.12cr. The list includes high-quality long-only investors such as Fidelity
As per the F&S Report, the company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. Here is a top thing to know about AMI Organics Limited IPO: 1.
The issue will have a price band of Rs522 to Rs531 per equity share of the face value of Re. 1 each (“Equity Shares”). Here is a top thing to know about Vijaya Diagnostic Center Limited IPO: 1) The Issue: The Initial Public Offering comprises of an offer